Article Versions Notes

Borges PHG, Gregio B, Suzukawa HT, Silva-Rodrigues G, Andreassa EdC, Castro IMd, Bartolomeu-Gonçalves G, Venancio EJ, Pinge-Filho P, Góes VM, et al. Strategy for the Construction of SARS-CoV-2 S and N Recombinant Proteins and Their Immunogenicity Evaluation. BioTech. 2025; 14(2):38. https://doi.org/10.3390/biotech14020038

Borges, Paulo Henrique Guilherme, Barbara Gregio, Helena Tiemi Suzukawa, Gislaine Silva-Rodrigues, Emanuella de Castro Andreassa, Isabela Madeira de Castro, Guilherme Bartolomeu-Gonçalves, Emerson José Venancio, Phileno Pinge-Filho, Viviane Monteiro Góes, and et al. 2025. "Strategy for the Construction of SARS-CoV-2 S and N Recombinant Proteins and Their Immunogenicity Evaluation" BioTech 14, no. 2: 38. https://doi.org/10.3390/biotech14020038

Borges, P. H. G., Gregio, B., Suzukawa, H. T., Silva-Rodrigues, G., Andreassa, E. d. C., Castro, I. M. d., Bartolomeu-Gonçalves, G., Venancio, E. J., Pinge-Filho, P., Góes, V. M., Nakamura, C. V., Tavares, E. R., Souza, T. d. A. C. B. d., Yamada-Ogatta, S. F., & Yamauchi, L. M. (2025). Strategy for the Construction of SARS-CoV-2 S and N Recombinant Proteins and Their Immunogenicity Evaluation. BioTech, 14(2), 38. https://doi.org/10.3390/biotech14020038